• Form 4 Oragenics Inc For: 7 July By Investing.com Investing.com Nigeria Tue, 07 Jul 2026 22:44:40 GMT
• Oragenics (OGEN) CFO receives 55,900 stock options at $0.59 exercise price Stock Titan Tue, 07 Jul 2026 21:51:27 GMT
• ORAGENICS (OGEN) CFO reports initial holdings, including 10,000-share stock option grant Stock Titan Tue, 07 Jul 2026 21:44:21 GMT
• Oragenics Activates All Australian Phase IIa Trial Sites for Concussion Drug ONP-002 citybuzz - Tue, 07 Jul 2026 17:49:51 GMT
• Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling GlobeNewswire Tue, 07 Jul 2026 12:30:00 GMT
• enterprise value to revenue forward of oragenics inc. – amex:ogen TradingView Tue, 30 Jun 2026 14:13:52 GMT
• OGEN Q2 2023 Earnings: Significant EPS Beat Amidst No Revenue Reported - Guidance vs Actual dars.gov.et Sun, 28 Jun 2026 07:00:00 GMT
• oragenics inc (ogen) valuation: pe, pb & fair value analysis TradingKey Fri, 26 Jun 2026 07:00:00 GMT
• oragenics inc (ogen) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 26 Jun 2026 06:40:59 GMT
• oragenics inc (ogen) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• oragenics inc (ogen) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 12:53:56 GMT
• Oragenics Inc (OGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 12:41:04 GMT
• oragenics inc (ogen) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 12:25:09 GMT
• oragenics inc (ogen) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 09:57:20 GMT
• oragenics inc (ogen) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 09:57:01 GMT
• oragenics inc (ogen) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 09:56:30 GMT
• oragenics inc (ogen) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 06:05:17 GMT
• oragenics inc (ogen) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 01:21:52 GMT
• ogen q2 2023 earnings: eps beat despite no revenue, stock declines - earnings yield spread newsline.com Tue, 16 Jun 2026 18:36:43 GMT
• oragenics inc (ogen) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• ogen q2 2023 earnings: loss narrower than expected but no revenue, stock declines - quarterly earnings report newsline.com Sat, 13 Jun 2026 10:40:34 GMT
• ogen q2 2023 earnings: eps beat on lower-than-expected loss, but stock declines - fiscal year earnings dars.gov.et Sat, 13 Jun 2026 07:00:00 GMT
• ogen q2 2023 earnings: narrower loss drives 5% bounce on surprise beat - revenue growth report newsline.com Fri, 12 Jun 2026 12:45:42 GMT
• oragenics inc. (ogen) gains ground: potential breakout above $0.65 in sight? - swing trade setups newsline.com Fri, 12 Jun 2026 00:30:13 GMT
• OGEN Q2 2023 Earnings: Smaller-Than-Expected Loss as Clinical Pipeline Progresses - Analyst Drop Coverage dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT
• oragenics inc. (ogen) edges lower to $0.60, testing key support levels - jelly roll trade newsline.com Tue, 09 Jun 2026 22:31:38 GMT
• ogen q2 2023 earnings: eps beats estimates by over 50% as company advances pipeline - banking earnings report newsline.com Tue, 09 Jun 2026 17:35:13 GMT
• oragenics inc. (ogen) inches higher as stock tests key resistance near $0.64 - supertrend flip newsline.com Fri, 29 May 2026 07:00:00 GMT
• ogen technical analysis | trend, signals & chart patterns | oragenics inc (nysearca:ogen) ChartMill Fri, 29 May 2026 07:00:00 GMT
• oragenics (ogen) short interest & short float | updated jun 2026 MarketBeat Fri, 29 May 2026 07:00:00 GMT
• oragenics inc. (ogen) slips amid low volume, hovers near key support - iceberg order newsline.com Tue, 26 May 2026 07:00:00 GMT
• oragenics inc. (ogen) edges higher as biotech volatility persists - rating change newsline.com Mon, 25 May 2026 07:00:00 GMT
• ogen q2 2023 earnings: narrower-than-expected loss boosts investor sentiment - open signal network Newser Mon, 25 May 2026 00:47:41 GMT
• ogen q2 2023 earnings: narrower-than-expected loss boosts investor sentiment - profit growth outlook thelegaladvocate.com Sun, 24 May 2026 07:00:00 GMT
• oragenics q2 2023 earnings: narrowing loss surprises, no revenue yet - earnings weakness phase The Legal Advocate Sun, 24 May 2026 04:34:21 GMT
• oragenics q2 2023 earnings: narrowing loss surprises, no revenue yet - long-term guidance newsline.com Sat, 23 May 2026 07:00:00 GMT
• ogen stock price, quote & chart | oragenics inc (nysearca:ogen) ChartMill Fri, 22 May 2026 07:00:00 GMT
• oragenics (ogen) rallies +4.50% as bulls target $0.63 2026-05-20 - symmetrical triangle newsline.com Wed, 20 May 2026 07:00:00 GMT
• oragenics to present at sidoti micro-cap virtual investor conference, highlighting progress on concussion treatment citybuzz - Tue, 19 May 2026 17:31:09 GMT
• Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21 Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• oragenics advances onp-002 phase iia in australia, $6.1m cash and loi for cns device TradingView Tue, 19 May 2026 07:00:00 GMT
• oragenics highlights investor outreach at micro-cap conference TipRanks Tue, 19 May 2026 07:00:00 GMT
• oragenics (ogen) q2 2023 beat: revenue $n/a, eps exceeds by significant - {璐㈡姤鍓爣棰榼 Newser Mon, 18 May 2026 22:39:26 GMT
• oragenics advances phase iia trial for concussion treatment, eyes cns expansion citybuzz - Mon, 18 May 2026 17:35:17 GMT
• oragenics (ogen) q2 2023 earnings: eps $-1.51 beats estimates - {璐㈡姤鍓爣棰榼 Newser Mon, 18 May 2026 15:58:12 GMT
• oragenics advances concussion drug trial, signs device loi by investing.com Investing.com Canada Mon, 18 May 2026 07:00:00 GMT
• oragenics (ogen) stock: down -2.94%, support test at $0.54 2026-05-18 - fibonacci arc newsline.com Mon, 18 May 2026 07:00:00 GMT
• oragenics (ogen) q2 2023 earnings surprise: eps $-1.51, up significant - free cash flow trends newsline.com Mon, 18 May 2026 07:00:00 GMT
• ogen technical analysis | trend, signals & chart patterns | oragenics inc (nysearca:ogen) ChartMill Thu, 14 May 2026 07:00:00 GMT
• oragenics (ogen) continues pipeline investments amid losses; ceo discusses strategic priorities and funding outlook. - crowd risk ... Newser Mon, 11 May 2026 07:00:00 GMT
• ogen technical analysis | trend, signals & chart patterns | oragenics inc (nysearca:ogen) ChartMill Mon, 11 May 2026 07:00:00 GMT
• oragenics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 08 May 2026 07:00:00 GMT
• ogen stock price, quote & chart | oragenics inc (nysearca:ogen) ChartMill Fri, 08 May 2026 07:00:00 GMT
• oragenics signs loi to license cardiodialysis technology for neurodegenerative diseases citybuzz - Thu, 07 May 2026 17:13:01 GMT
• oragenics inc - signs letter of intent to license cardiodialysis from sigyn therapeutics - sec filing TradingView Thu, 07 May 2026 12:19:16 GMT
• Oragenics Signs Letter of Intent to License CardioDialysis™ GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• oragenics signs letter of intent to license blood purification tech by investing.com Investing.com Canada Thu, 07 May 2026 07:00:00 GMT
• oragenics adds second site to concussion drug trial in australia by investing.com Investing.com India Wed, 06 May 2026 07:31:42 GMT
• Oragenics opens second site for ONP-002 Phase IIa trial Clinical Trials Arena Wed, 06 May 2026 07:00:00 GMT
• oragenics expands phase iia trial for concussion treatment to second site MEXC Exchange Wed, 06 May 2026 04:27:51 GMT
• oragenics, inc. opens second clinical site for phase iia trial of onp-002, evaluating treatment for concussion with 60 participant... geneonline.com Tue, 05 May 2026 20:48:40 GMT
• oragenics activates second site in phase iia clinical trial of onp-002 for concussion and mild traumatic brain injury. GlobeNewswire Tue, 05 May 2026 07:00:00 GMT
• oragenics activates second site in phase iia trial for concussion drug onp-002, enrolling patients rapidly. Pluang Tue, 05 May 2026 07:00:00 GMT
• oragenics adds second site to concussion drug trial in australia Investing.com Tue, 05 May 2026 07:00:00 GMT
• oragenics expands phase iia trial for concussion treatment to second site MEXC Tue, 05 May 2026 07:00:00 GMT
• oragenics shares plunge following announcement of $20 million preferred stock sale MSN Mon, 27 Apr 2026 16:41:44 GMT
• oragenics shares plunge following announcement of $20 million preferred stock sale MSN Sun, 26 Apr 2026 05:36:31 GMT
• oragenics shares plunge following announcement of $20 million preferred stock sale MSN Sat, 25 Apr 2026 04:56:02 GMT
• oragenics shares plunge following announcement of $20 million preferred stock sale MSN Fri, 24 Apr 2026 18:46:23 GMT
• ogen stock price, quote & chart | oragenics inc (nysearca:ogen) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• oragenics shares plunge following announcement of $20 million preferred stock sale MSN Tue, 21 Apr 2026 05:52:56 GMT
• oragenics (ogen) advances in phase iia trial for concussion trea GuruFocus Mon, 20 Apr 2026 18:11:15 GMT
• oragenics announces 8 drug doses administered in phase iia trial of onp-002 TipRanks Mon, 20 Apr 2026 15:05:26 GMT
• oragenics reports 8 study drug doses in phase iia clinical trial of onp-002 for mild traumatic brain injury GlobeNewswire Mon, 20 Apr 2026 07:00:00 GMT
• concussion has no approved drug; oragenics doses 2 in trial Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• oragenics reports early progress in phase iia trial of intranasal concussion therapy citybuzz - Mon, 20 Apr 2026 07:00:00 GMT
• ogen stock price, quote & chart | oragenics inc (nysearca:ogen) ChartMill Fri, 17 Apr 2026 07:00:00 GMT
• ogen forecast, price target & analyst ratings | oragenics inc (nysearca:ogen) ChartMill Wed, 15 Apr 2026 07:00:00 GMT
• earnings recap: is oragenics inc gaining market share - weekly stock report & weekly high momentum picks baoquankhu1.vn Mon, 13 Apr 2026 17:32:34 GMT
• oragenics doses first patient in phase iia trial for potential concussion treatment citybuzz - Mon, 13 Apr 2026 16:36:18 GMT
• Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury Yahoo Finance Mon, 13 Apr 2026 07:00:00 GMT
• oragenics doses first patient in phase iia trial of onp-002 for concussion, targeting unmet need in mild traumatic brain injury 1 Minichart Mon, 13 Apr 2026 07:00:00 GMT
• with no approved concussion drug, oragenics starts patient dosing Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
• oragenics begins phase iia dosing of concussion drug onp-002 in australia TipRanks Mon, 13 Apr 2026 07:00:00 GMT
• sectors review: is oragenics inc stock technically oversold - 2026 institutional & stepwise entry/exit trade alerts baoquankhu1.vn Sat, 11 Apr 2026 11:38:38 GMT
• oragenics (ogen) short interest & short float | updated apr 2026 MarketBeat Fri, 10 Apr 2026 07:00:00 GMT
• nasdaq moves: is oragenics inc vulnerable to short sellers - quarterly market review & risk controlled stock pick alerts baoquankhu1.vn Thu, 09 Apr 2026 23:14:08 GMT
• risk on: is oragenics inc gaining market share - price action & advanced technical signal analysis baoquankhu1.vn Thu, 09 Apr 2026 11:09:55 GMT
• rally mode: is oragenics inc gaining market share - 2026 trading volume trends & long-term capital growth strategies baoquankhu1.vn Thu, 09 Apr 2026 11:06:24 GMT
• can oragenics (ogen) stock rebound in 2026 | price at $0.61, up 8.48% - retracement entry The Legal Advocate Mon, 06 Apr 2026 07:00:00 GMT
• 0a64.il,0p0001ll1f,111 (0a64.il) latest press releases & corporate news Yahoo! Finance Canada Sat, 04 Apr 2026 12:45:18 GMT
• oragenics inc (uav.be) stock price, news, quote & history Yahoo! Finance Canada Fri, 03 Apr 2026 20:15:02 GMT
• ogen stock price, quote & chart | oragenics inc (nysearca:ogen) ChartMill Thu, 02 Apr 2026 07:00:00 GMT
• oragenics sets new 2025 annual shareholder meeting date The Globe and Mail Wed, 01 Apr 2026 07:00:00 GMT
• oragenics: ceo highlights "undervalued" pipeline amid significant insider sale of 35% ownership bitget.com Wed, 01 Apr 2026 00:08:08 GMT
• oragenics: ceo highlights "undervalued" pipeline amid significant insider sale of 35% ownership Bitget Tue, 31 Mar 2026 09:03:53 GMT
• oragenics (ogen) schedules 2025 shareholder meeting and sets may 1, 2026 proposal cutoff Stock Titan Tue, 31 Mar 2026 07:00:00 GMT
• ogen stock price, quote & chart | oragenics inc (nysearca:ogen) ChartMill Tue, 31 Mar 2026 07:00:00 GMT
• risks report: what is the target price for oragenics inc stock - dollar strength & real-time stock movement alerts baoquankhu1.vn Sun, 29 Mar 2026 07:00:33 GMT
• ogen stock price, quote & chart | oragenics inc (nysearca:ogen) ChartMill Fri, 27 Mar 2026 07:00:00 GMT
• ogen forecast, price target & analyst ratings | oragenics inc (nysearca:ogen) ChartMill Fri, 27 Mar 2026 07:00:00 GMT
• oragenics receives going concern qualification amid clinical trial preparations citybuzz - Thu, 26 Mar 2026 22:28:19 GMT
• oragenics, inc. receives audit opinion with going concern explanation Sahm Thu, 26 Mar 2026 07:00:00 GMT
• oragenics receives audit opinion with going concern explanation TipRanks Thu, 26 Mar 2026 02:47:15 GMT
• oragenics (ogen) reports going concern risk in latest audit GuruFocus Wed, 25 Mar 2026 23:03:01 GMT
• nyse rule forces oragenics to flag going concern audit note Stock Titan Wed, 25 Mar 2026 22:30:00 GMT
• Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation Yahoo Finance Wed, 25 Mar 2026 07:00:00 GMT
• oragenics receives audit opinion with going concern explanation TipRanks Wed, 25 Mar 2026 07:00:00 GMT
• volume recap: is oragenics inc vulnerable to short sellers - 2026 support & resistance & long hold capital preservation tips baoquankhu1.vn Mon, 23 Mar 2026 14:40:33 GMT
• growth report: is oragenics inc forming bullish engulfing patterns - 2026 decliners & ai powered buy/sell recommendations baoquankhu1.vn Sun, 22 Mar 2026 09:48:42 GMT
• oragenics, inc.: fundamental analysis and financial ratings | uav0 | us6840236094 marketscreener.com Fri, 20 Mar 2026 08:39:04 GMT
• ogen forecast, price target & analyst ratings | oragenics inc (nysearca:ogen) ChartMill Fri, 20 Mar 2026 07:00:00 GMT
• oragenics (nasdaq: ogen) updates s-3/a with auditor consent Stock Titan Thu, 19 Mar 2026 07:00:00 GMT
• oragenics files 2025 annual report, highlights progress in concussion treatment development citybuzz - Tue, 17 Mar 2026 19:54:20 GMT
• oragenics submits annual report highlighting fiscal year 2025 financials and research updates geneonline.com Tue, 17 Mar 2026 13:01:27 GMT
• biotech oragenics raises $16.5m, clears debt to fund concussion drug trial Stock Titan Tue, 17 Mar 2026 07:00:00 GMT
• oragenics, inc. reports earnings results for the full year ended december 31, 2025 MarketScreener Mon, 16 Mar 2026 07:00:00 GMT
• oragenics, inc. auditor raises 'going concern' doubt marketscreener.com Sun, 15 Mar 2026 07:00:00 GMT
• oragenics initiates first clinical site for phase iia trial of intranasal concussion treatment citybuzz - Fri, 13 Mar 2026 07:08:12 GMT
• oragenics inc initiates phase iia clinical trial site activation marketscreener.com Thu, 12 Mar 2026 18:35:37 GMT
• oragenics (ogen) advances phase iia clinical trial of onp-002 in australia GuruFocus Thu, 12 Mar 2026 07:00:00 GMT
• oragenics initiates phase iia clinical trial site activation Yahoo Finance Thu, 12 Mar 2026 07:00:00 GMT
Oragenics, Inc(NYSE MKT:OGEN) 
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Its lead product candidate under development is OG716, an antibiotic for the treatment of Clostridium difficile. The company also engages in the development and commercialization of Terra CoV-2, a vaccine product cand...
Website: http://www.oragenics.com
Founded: 1996
Full Time Employees: 7
Sector: Healthcare
Industry: Biotechnology